The United States produces roughly 3% of the active pharmaceutical ingredients in the world. Meanwhile, produces a whopping 45%. A Johns Hopkins study found that China supplies more than 60% of the essential components American manufacturers need for antibiotics.
Thats not just a trade imbalance, it is surrendering sovereignty.
The our children and our neighbors is beholden to an adversary who could weaponize not just the availability of and access to essential medications but the safety of those very products.
ROBERT F KENNEDY JR: THE FUTURE OF MEDICINE SHOULD BE BUILT IN AMERICA
We didnt get here by accident. Decades of offshoring gutted the American industrial base and As recently as 1981, the United States produced 25% of the worlds pharmaceutical ingredients. Today, China controls nearly half the global market. A nation that cannot make its own antibiotics and cannot stop adversary-sourced chemicals from crossing its border does not fully govern itself.
The Council on Foreign Relations called this what it is: a pharma choke point. The dependence is structural, deep and spreading from generics into advanced biologics.
CORPORATE AMERICA’S CHINA ADDICTION HAS BECOME A NATIONAL SECURITY THREAT
Beijing has already shown it will weaponize supply chains. It did so with rare earths, semiconductor inputs and defense-critical metals. Why would we believe the Chinese Communist Party (CCP) would treat medicine any differently in a crisis when it has the capacity to poison an entire people?
The same chemical networks that feed Chinese precursors into American pharmacies also feed the fentanyl pipeline through Mexico. Research from the University of Virginias National Security Data and Policy Institute describes Chinese suppliers and Mexican cartels as a singular adaptive supply chain: precursors bought cheaply online, air-shipped in bulk, converted into pills, and pushed across the border.
A few thousand dollars of chemicals can buy millions of doses. The wreckage in Midwestern towns is not a mystery. It is the real-life effect of a Chinese chemical distribution system operating behind a cartel front.
Congress has rightly begun to respond. The BIOSECURE Act, signed into law in December 2025, restricts federal procurement involving biotechnology products from designated companies tied to foreign adversaries. President Donald Trump also took executive action on tariffs targeting the synthetic opioid supply chain. Those steps matter. But they dont build manufacturing plants.
EXCLUSIVE: FENTANYL DEATHS PLUNGE 22% AS TRUMP WHITE HOUSE TOUTS CRACKDOWN ON DEADLY DRUG CRISIS
Legislation alone does not build a factory, bring jobs back and secure our nation. To effectively pry Chinas grip off our supply chain, we must invest heavily in domestic producers. We need to build the manufacturing facilities here at home.
T
